SSA
BSX icon

Schonfeld Strategic Advisors’s Boston Scientific BSX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-62,500
Closed -$6.3M – 2065
2025
Q1 		$6.3M Buy
+62,500
New +$6.29M 0.04% 459

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Schonfeld Strategic Advisors's BSX Position: Q1 2026 in Review

Schonfeld Strategic Advisors increased its Boston Scientific (BSX) stake by 84% in Q1 2026, buying an estimated $40.5M and bringing the position to 1,105,515 shares worth $69.4M. The position accounts for 0.49% of the portfolio, ranked #20.

Schonfeld Strategic Advisors first reported a position in BSX in Q3 2016 and has held it in 39 quarters since. The position peaked at $91.8M in Q3 2025. 1,667 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Schonfeld Strategic Advisors held 1,105,515 shares of Boston Scientific worth $69.4M as of Q1 2026.
  • Schonfeld Strategic Advisors bought 506,234 Boston Scientific shares in Q1 2026, an estimated $40.5M.
  • Boston Scientific made up 0.49% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #20 holding.
  • Schonfeld Strategic Advisors first reported a position in Boston Scientific in Q3 2016 and has held it in 39 quarters since.
  • Schonfeld Strategic Advisors's Boston Scientific position peaked at $91.8M in Q3 2025.
  • 1,667 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.